Evaluation of gut microbial signature and stool metabolites in healthy individuals and patients suffering from colorectal cancer (CRC) and ulcerative colitis (UC) using BugSpeaks microbiome analytical platform – An observational, non-interventional, prospective, multi-centric study - NI

For BugWorks Research India Pvt Ltd Leucine Rich Bio Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•Healthy Human Volunteers:
•Overall Healthy Male and female subjects of age between 30 and 70 years (both inclusive), not taking any regular medications
•Ulcerative Colitis Group:
•1. Subjects with documented (colonoscopy) evidence of Ulcerative colitis (UC) without complications.
•Colorectal Cancer Group:
•1. Subjects with documented (colonoscopy and biopsy) evidence of exclusive Colorectal Cancer (CRC) without any metastasis

•Healthy Human Volunteers:
•1. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention
•2.Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis and Cancer etc.
•2. Ulcerative Colitis Group:
•1.Subject has had or is expected to have surgery for active gastrointestinal bleeding, peritonitis, intestinal obstruction, or intra-abdominal abscess requiring surgical drainage, or other conditions that may confound study evaluations
•2.Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject.
•3. Colorectal Cancer Group:
•1. Subjects with metastatic Colorectal Cancer
•2.Subject has had or is expected to have surgery for active gastrointestinal bleeding, peritonitis, intestinal obstruction, or intra-abdominal abscess requiring surgical drainage, or other conditions that may confound study evaluations

发起方

For BugWorks Research India Pvt Ltd Leucine Rich Bio Pvt Ltd